TY - JOUR
T1 - COVID-19 vaccine equity: a health systems and policy perspective
AU - van de Pas, Remco
AU - Widdowson, Marc-Alain
AU - Ravinetto, Raffaella
AU - N Srinivas, Prashanth
AU - Ochoa, Theresa J
AU - Fofana, Thierno Oumar
AU - Van Damme, Wim
N1 - NPP
PY - 2022
Y1 - 2022
N2 - INTRODUCTION: The global COVID-19 vaccine rollout has highlighted inequities in the accessibility of countries to COVID-19 vaccines. Populations in low- and middle-income countries have found it difficult to have access to COVID-19 vaccines.AREAS COVERED: This perspective provides analyses on historical and contemporary policy trends of vaccine development and immunization programs, including the current COVID-19 vaccination drive, and governance challenges. Moreover, we also provide a comparative health system analysis of the COVID-19 vaccine deployment in some countries from different continents. It recommends that the international Access to COVID-19 Tools Accelerator (ACT-A) partnership requires a strong governance mechanism and urgent financial investment.EXPERT OPINION: All WHO member states should agree on technology transfer and voluntary license-sharing via a commonly governed technology access pool and supported by a just Intellectual Property regime. Contextualized, dynamic understandings and country-specific versions of health systems strengthening are needed to improve vaccine equity in a sustainable matter.
AB - INTRODUCTION: The global COVID-19 vaccine rollout has highlighted inequities in the accessibility of countries to COVID-19 vaccines. Populations in low- and middle-income countries have found it difficult to have access to COVID-19 vaccines.AREAS COVERED: This perspective provides analyses on historical and contemporary policy trends of vaccine development and immunization programs, including the current COVID-19 vaccination drive, and governance challenges. Moreover, we also provide a comparative health system analysis of the COVID-19 vaccine deployment in some countries from different continents. It recommends that the international Access to COVID-19 Tools Accelerator (ACT-A) partnership requires a strong governance mechanism and urgent financial investment.EXPERT OPINION: All WHO member states should agree on technology transfer and voluntary license-sharing via a commonly governed technology access pool and supported by a just Intellectual Property regime. Contextualized, dynamic understandings and country-specific versions of health systems strengthening are needed to improve vaccine equity in a sustainable matter.
KW - COVID-19
KW - COVID-19 Vaccines
KW - Delivery of Health Care
KW - Health Policy
KW - Healthcare Disparities
KW - Humans
U2 - 10.1080/14760584.2022.2004125
DO - 10.1080/14760584.2022.2004125
M3 - A1: Web of Science-article
C2 - 34758678
SN - 1476-0584
VL - 21
SP - 25
EP - 36
JO - Expert Review of Vaccines
JF - Expert Review of Vaccines
IS - 1
ER -